Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Pancreatic and Bile Duct Cancer Drug Market Size Growth Rate by Type (2014-2025) 1.4.2 Vascular Endothelial Growth Factor Receptors 1.4.3 Programmed Cell Death Protein 1 1.4.4 Signal Transducer Activator of Transcription 3 1.4.5 Others 1.5 Market by Application 1.5.1 Global Pancreatic and Bile Duct Cancer Drug Market Share by Application (2019-2025) 1.5.2 Pancreatic Cancer 1.5.3 Cholangiocarcinoma 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Pancreatic and Bile Duct Cancer Drug Market Size 2.2 Pancreatic and Bile Duct Cancer Drug Growth Trends by Regions 2.2.1 Pancreatic and Bile Duct Cancer Drug Market Size by Regions (2019-2025) 2.2.2 Pancreatic and Bile Duct Cancer Drug Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Pancreatic and Bile Duct Cancer Drug Market Size by by Players 3.1.1 Global Pancreatic and Bile Duct Cancer Drug Revenue by by Players (2014-2019) 3.1.2 Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by by Players (2014-2019) 3.1.3 Global Pancreatic and Bile Duct Cancer Drug Market Concentration Ratio (CR5 and HHI) 3.2 Pancreatic and Bile Duct Cancer Drug Key Players Head office and Area Served 3.3 Key Players Pancreatic and Bile Duct Cancer Drug Product/Solution/Service 3.4 Date of Enter into Pancreatic and Bile Duct Cancer Drug Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Pancreatic and Bile Duct Cancer Drug Market Size by Type (2014-2019) 4.2 Global Pancreatic and Bile Duct Cancer Drug Market Size by Application (2014-2019) 5 North America 5.1 North America Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 5.2 Pancreatic and Bile Duct Cancer Drug Key Players in North America 5.3 North America Pancreatic and Bile Duct Cancer Drug Market Size by Type 5.4 North America Pancreatic and Bile Duct Cancer Drug Market Size by Application 6 Europe 6.1 Europe Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 6.2 Pancreatic and Bile Duct Cancer Drug Key Players in Europe 6.3 Europe Pancreatic and Bile Duct Cancer Drug Market Size by Type 6.4 Europe Pancreatic and Bile Duct Cancer Drug Market Size by Application 7 China 7.1 China Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 7.2 Pancreatic and Bile Duct Cancer Drug Key Players in China 7.3 China Pancreatic and Bile Duct Cancer Drug Market Size by Type 7.4 China Pancreatic and Bile Duct Cancer Drug Market Size by Application 8 Japan 8.1 Japan Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 8.2 Pancreatic and Bile Duct Cancer Drug Key Players in Japan 8.3 Japan Pancreatic and Bile Duct Cancer Drug Market Size by Type 8.4 Japan Pancreatic and Bile Duct Cancer Drug Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 9.2 Pancreatic and Bile Duct Cancer Drug Key Players in Southeast Asia 9.3 Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size by Type 9.4 Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size by Application 10 India 10.1 India Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 10.2 Pancreatic and Bile Duct Cancer Drug Key Players in India 10.3 India Pancreatic and Bile Duct Cancer Drug Market Size by Type 10.4 India Pancreatic and Bile Duct Cancer Drug Market Size by Application 11 Central & South America 11.1 Central & South America Pancreatic and Bile Duct Cancer Drug Market Size (2014-2019) 11.2 Pancreatic and Bile Duct Cancer Drug Key Players in Central & South America 11.3 Central & South America Pancreatic and Bile Duct Cancer Drug Market Size by Type 11.4 Central & South America Pancreatic and Bile Duct Cancer Drug Market Size by Application 12 International Players Profiles 12.1 3-V Biosciences Inc 12.1.1 3-V Biosciences Inc Company Details 12.1.2 Company Description and Business Overview 12.1.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.1.4 3-V Biosciences Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019)) 12.1.5 3-V Biosciences Inc Recent Development 12.2 4P-Pharma SAS 12.2.1 4P-Pharma SAS Company Details 12.2.2 Company Description and Business Overview 12.2.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.2.4 4P-Pharma SAS Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.2.5 4P-Pharma SAS Recent Development 12.3 4SC AG 12.3.1 4SC AG Company Details 12.3.2 Company Description and Business Overview 12.3.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.3.4 4SC AG Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.3.5 4SC AG Recent Development 12.4 AB Science SA 12.4.1 AB Science SA Company Details 12.4.2 Company Description and Business Overview 12.4.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.4.4 AB Science SA Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.4.5 AB Science SA Recent Development 12.5 AbbVie Inc 12.5.1 AbbVie Inc Company Details 12.5.2 Company Description and Business Overview 12.5.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.5.4 AbbVie Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.5.5 AbbVie Inc Recent Development 12.6 AbGenomics International Inc 12.6.1 AbGenomics International Inc Company Details 12.6.2 Company Description and Business Overview 12.6.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.6.4 AbGenomics International Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.6.5 AbGenomics International Inc Recent Development 12.7 Ability Pharmaceuticals SL 12.7.1 Ability Pharmaceuticals SL Company Details 12.7.2 Company Description and Business Overview 12.7.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.7.4 Ability Pharmaceuticals SL Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.7.5 Ability Pharmaceuticals SL Recent Development 12.8 Aclaris Therapeutics Inc 12.8.1 Aclaris Therapeutics Inc Company Details 12.8.2 Company Description and Business Overview 12.8.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.8.4 Aclaris Therapeutics Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.8.5 Aclaris Therapeutics Inc Recent Development 12.9 Actuate Therapeutics Inc 12.9.1 Actuate Therapeutics Inc Company Details 12.9.2 Company Description and Business Overview 12.9.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.9.4 Actuate Therapeutics Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.9.5 Actuate Therapeutics Inc Recent Development 12.10 Aduro BioTech Inc 12.10.1 Aduro BioTech Inc Company Details 12.10.2 Company Description and Business Overview 12.10.3 Pancreatic and Bile Duct Cancer Drug Introduction 12.10.4 Aduro BioTech Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) 12.10.5 Aduro BioTech Inc Recent Development 12.11 Advantagene Inc 12.12 AGV Discovery SAS 12.13 AIMM Therapeutics BV 12.14 Alissa Pharma 12.15 Alligator Bioscience AB 12.16 Allinky Biopharma 12.17 Altor BioScience Corp 12.18 amcure GmbH 12.19 Amgen Inc 12.20 Amplia Therapeutics Pty Ltd 12.21 Anavex Life Sciences Corp 12.22 Andarix Pharmaceuticals Inc 12.23 ANP Technologies Inc 12.24 AntiCancer Inc 12.25 APEIRON Biologics AG 12.26 Apexigen Inc 12.27 Aphios Corp 12.28 Aposense Ltd 12.28 ARMO Biosciences Inc 12.40 ArQule Inc 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Pancreatic and Bile Duct Cancer Drug Key Market Segments Table Key Players Pancreatic and Bile Duct Cancer Drug Covered Table Global Pancreatic and Bile Duct Cancer Drug Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Vascular Endothelial Growth Factor Receptors Figures Table Key Players of Vascular Endothelial Growth Factor Receptors Figuer Programmed Cell Death Protein 1 Figures Table Key Players of Programmed Cell Death Protein 1 Figuer Signal Transducer Activator of Transcription 3 Figures Table Key Players of Signal Transducer Activator of Transcription 3 Figuer Others Figures Table Key Players of Others Table Global Pancreatic and Bile Duct Cancer Drug Market Size Growth by Application 2019-2025 (Million US$) Figure Global Pancreatic and Bile Duct Cancer Drug Market Share by Application in 2018 & 2025 Figure Pancreatic Cancer Case Studies Figure Cholangiocarcinoma Case Studies Figure Pancreatic and Bile Duct Cancer Drug Report Years Considered Figure Global Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate 2014-2025 (Million US$) Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Regions 2019-2025 (Million US$) Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Regions 2019-2025 (Million US$) Table Global Pancreatic and Bile Duct Cancer Drug Market Share by Regions 2014-2019 Figure Global Pancreatic and Bile Duct Cancer Drug Market Share by Regions 2014-2019 Figure Global Pancreatic and Bile Duct Cancer Drug Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Pancreatic and Bile Duct Cancer Drug Revenue by by Players (2014-2019) (Million US$) Table Global Pancreatic and Bile Duct Cancer Drug Market Share by by Players (2014-2019) Figure Global Pancreatic and Bile Duct Cancer Drug Market Share by by Players in 2018 Table Global Pancreatic and Bile Duct Cancer Drug by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Pancreatic and Bile Duct Cancer Drug Product/Solution/Service Table Date of Enter into Pancreatic and Bile Duct Cancer Drug Market Table Mergers & Acquisitions, Expansion Plans Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Type (2014-2019) (Million US$) Table Global Pancreatic and Bile Duct Cancer Drug Market Size Share by Type (2014-2019) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size Market Share by Type (2014-2019) Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Application (2014-2019) (Million US$) Table Global Pancreatic and Bile Duct Cancer Drug Market Size Share by Application (2014-2019) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size Market Share by Application (2014-2019) Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Application in 2018 Figure North America Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table North America Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table North America Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table North America Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table North America Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table North America Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table North America Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Figure Europe Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table Europe Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table Europe Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table Europe Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table Europe Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table Europe Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table Europe Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Figure China Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table China Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table China Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table China Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table China Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table China Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table China Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Figure Japan Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table Japan Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table Japan Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table Japan Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table Japan Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table Japan Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table Japan Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Figure Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Figure India Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table India Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table India Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table India Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table India Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table India Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table India Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Figure Central & South America Pancreatic and Bile Duct Cancer Drug Market Size 2014-2019 (Million US$) Table Central & South America Key Players Pancreatic and Bile Duct Cancer Drug Revenue (2018-2019) (Million US$) Table Central & South America Key Players Pancreatic and Bile Duct Cancer Drug Market Share (2018-2019) Table Central & South America Pancreatic and Bile Duct Cancer Drug Market Size by Type 2014-2019 (Million US$) Table Central & South America Pancreatic and Bile Duct Cancer Drug Market Share by Type 2014-2019 Table Central & South America Pancreatic and Bile Duct Cancer Drug Market Size by Application 2014-2019 (Million US$) Table Central & South America Pancreatic and Bile Duct Cancer Drug Market Share by Application 2014-2019 Table 3-V Biosciences Inc Company Details Table 3-V Biosciences Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure 3-V Biosciences Inc Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table 3-V Biosciences Inc Recent Development Table 4P-Pharma SAS Company Details Table 4P-Pharma SAS Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure 4P-Pharma SAS Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table 4P-Pharma SAS Recent Development Table 4SC AG Company Details Table 4SC AG Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure 4SC AG Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table 4SC AG Recent Development Table AB Science SA Company Details Table AB Science SA Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure AB Science SA Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table AB Science SA Recent Development Table AbbVie Inc Company Details Table AbbVie Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure AbbVie Inc Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table AbbVie Inc Recent Development Table AbGenomics International Inc Company Details Table AbGenomics International Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure AbGenomics International Inc Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table AbGenomics International Inc Recent Development Table Ability Pharmaceuticals SL Company Details Table Ability Pharmaceuticals SL Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure Ability Pharmaceuticals SL Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table Ability Pharmaceuticals SL Recent Development Table Aclaris Therapeutics Inc Company Details Table Aclaris Therapeutics Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure Aclaris Therapeutics Inc Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table Aclaris Therapeutics Inc Recent Development Table Actuate Therapeutics Inc Company Details Table Actuate Therapeutics Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure Actuate Therapeutics Inc Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table Actuate Therapeutics Inc Recent Development Table Aduro BioTech Inc Company Details Table Aduro BioTech Inc Revenue in Pancreatic and Bile Duct Cancer Drug Business 2014-2019 (Million US$) Figure Aduro BioTech Inc Revenue Growth Rate in Pancreatic and Bile Duct Cancer Drug Business (2014-2019) Table Aduro BioTech Inc Recent Development Table Advantagene Inc Company Details Table AGV Discovery SAS Company Details Table AIMM Therapeutics BV Company Details Table Alissa Pharma Company Details Table Alligator Bioscience AB Company Details Table Allinky Biopharma Company Details Table Altor BioScience Corp Company Details Table amcure GmbH Company Details Table Amgen Inc Company Details Table Amplia Therapeutics Pty Ltd Company Details Table Anavex Life Sciences Corp Company Details Table Andarix Pharmaceuticals Inc Company Details Table ANP Technologies Inc Company Details Table AntiCancer Inc Company Details Table APEIRON Biologics AG Company Details Table Apexigen Inc Company Details Table Aphios Corp Company Details Table Aposense Ltd Company Details Table ARMO Biosciences Inc Company Details Table ArQule Inc Company Details Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Regions (Million US$) 2019-2025 Figure Global Pancreatic and Bile Duct Cancer Drug Market Size Share by Regions (2019-2025) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size Share by Regions in 2025 Figure North America Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Europe Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure China Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Japan Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure India Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2025)(Million USD) Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Product (2019-2025) (Million US$) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size by Product (2019-2025) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size by Product in 2025 Table Global Pancreatic and Bile Duct Cancer Drug Market Size by Application (2019-2025) (Million US$) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size by Application (2019-2025) Figure Global Pancreatic and Bile Duct Cancer Drug Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

3-V Biosciences Inc 4P-Pharma SAS 4SC AG AB Science SA AbbVie Inc AbGenomics International Inc Ability Pharmaceuticals SL Aclaris Therapeutics Inc Actuate Therapeutics Inc Aduro BioTech Inc Advantagene Inc AGV Discovery SAS AIMM Therapeutics BV Alissa Pharma Alligator Bioscience AB Allinky Biopharma Altor BioScience Corp amcure GmbH Amgen Inc Amplia Therapeutics Pty Ltd Anavex Life Sciences Corp Andarix Pharmaceuticals Inc ANP Technologies Inc AntiCancer Inc APEIRON Biologics AG Apexigen Inc Aphios Corp Aposense Ltd ARMO Biosciences Inc ArQule Inc